Involvement of opioid mechanisms in peripheral motor control of detrusor muscle

Pharmacol Toxicol. 1992 Sep;71(3 Pt 1):179-84. doi: 10.1111/j.1600-0773.1992.tb00541.x.

Abstract

Isometric recordings of mechanical activity in muscle strips from rat and human detrusor were performed and the effect of mu- and delta-opioid receptor stimulation and blockade on detrusor contraction induced by electrical field stimulation was tested. Stimulation of the opioid mu-receptor with morphine (10(-13)-10(-4) M) and DAGO (10(-13)-10(-6) M) had no significant effect on electrical field stimulation except at one concentration of morphine (10(-6) M). Naloxone (10(-10)-10(-5) M) caused a significant facilitation of the electrical field stimulation-induced contraction, which was counteracted by morphine (10(-8) M) and the delta-agonist DPDPE (10(-8) M) in both rat and human detrusor. Addition of atropine (10(-6) M) or hexamethonium chloride (10(-6) M) or spantide (10(-6) M) did not alter the facilitating effect of naloxone in the rat detrusor. Hexamethonium (10(-5) M) decreased the facilitating effect of naloxone on electrical field stimulation-induced contractions in the human detrusor, indicating involvement of ganglionic mechanisms. In human detrusor about 15% of the contractile response was found to be atropine-resistant (10(-6) M) and one third of this was found to be resistant to tetrodotoxin (1.5 x 10(-6) M). The atropine resistant-response in human detrusor was facilitated by naloxone to the same extent as the atropine-sensitive part. Adrenergic blockade per se, achieved with phentolamine mesylate (10(-6) M) and propranolol (10(-6) M), caused a significant facilitation of the electrical field stimulation-induced contraction in the rat detrusor but did not affect the facilitating effect of naloxone (10(-13)-10(-5) M).(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Electric Stimulation
  • Enkephalins / pharmacology
  • Ganglionic Blockers / pharmacology
  • Hexamethonium
  • Hexamethonium Compounds / pharmacology
  • Humans
  • Indoles / pharmacology
  • Male
  • Morphinans / pharmacology
  • Morphine / pharmacology
  • Muscle Contraction / drug effects*
  • Muscle Contraction / physiology
  • Muscles / drug effects
  • Muscles / physiology*
  • Naloxone / pharmacology
  • Naltrexone* / analogs & derivatives*
  • Narcotic Antagonists / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, delta / drug effects
  • Receptors, Opioid, delta / physiology*
  • Receptors, Opioid, mu / drug effects
  • Receptors, Opioid, mu / physiology*
  • Substance P / analogs & derivatives
  • Substance P / pharmacology
  • Sympatholytics / pharmacology

Substances

  • Enkephalins
  • Ganglionic Blockers
  • Hexamethonium Compounds
  • Indoles
  • Morphinans
  • Narcotic Antagonists
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu
  • Sympatholytics
  • Substance P
  • Naloxone
  • Hexamethonium
  • Naltrexone
  • Morphine
  • spantide
  • naltrindole